Dr Peter Norman
Apr 1, 2007
Citations
0
Influential Citations
3
Citations
Journal
Expert Opinion on Therapeutic Patents
Abstract
Three applications claim 3-aroyl-9-phenoxyphenyl-3,9-diazaspiro[5.5]undecane derivatives and their salts. The compounds are CCR8 antagonists, claimed to be useful in treating chemokine-mediated diseases, especially respiratory diseases. Their use for the treatment of asthma, chronic obstructive pulmonary disease and rhinitis is claimed.